IMPACT BIOMEDICAL INC. - 8-K Filing

Impact BioMedical completes business combination with Zoar Limited via merger, resulting in a change of control and delisting from NYSE American. (Items: 2.01 Completion of Acquisition or Disposition of Assets, 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, 3.03 Material Modification to Rights of Security Holders, 5.01 Item 5)

SEC EDGAR ·

Tickers: $IBO

Read the full article at SEC EDGAR

More Regulatory news